𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical experience in the treatment of the “red nose” using the flashlamp-pumped pulsed dye laser (585 nm)

✍ Scribed by J. H. Scheepers; A. A. Quaba


Publisher
Springer
Year
1994
Tongue
English
Weight
344 KB
Volume
18
Category
Article
ISSN
0364-216X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Progressive ascending telangiectasia tre
✍ Pérez, Bibiana; Nuñez, María; Boixeda, Pablo; Harto, Antonio; Ledo, Antonio 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Background and Objective: Progressive ascending telangiectasia (PAT) is a distinct entity with telangiectatic superficial vessels on lower extremities as its main clinical feature. A relationship with occult infections and response to antibiotic and antifungal drugs have been described, although not

Effectiveness of the 585nm flashlamp-pul
✍ Jain, Ajay; Storwick, Gregory S. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Background and Objective: The objective of this study was to establish the 585nm flashlamp-pulsed tunable dye laser (PTDL) as a potentially effective modality in the treatment of plantar verrucae. Furthermore, this study attempted to identify if certain regions of the plantar surface yielded a diffe

Five years' experience of treating port
✍ G.A. KATUGAMPOLA; S.W. LANIGAN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

During the last 5 years, 640 patients had treatment to their port wine stains (PWS) with a flashlamp-pumped pulsed dye laser. One hundred and fifty-six patients have been discharged for varying reasons, of which 59 (38%) achieved excellent (at least 75%) lightening of their birthmark. Of the remaini

Treatment of cutaneous hemangiomas in pr
✍ Ricci, Rita M.; Finley, Eric M.; Grimwood, Ronald E. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Background and Objective: We report two cases of hemangiomas in twins born at a gestational age of 30 weeks who were treated with a flashlamp-pumped pulsed dye laser (FPDL) at 40 days postpartem. These were the youngest patients to our knowledge to be treated with FPDL. Study Design/Patients an